DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development
Open Access
- 23 February 2021
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 324, 123-132
- https://doi.org/10.1016/j.atherosclerosis.2021.02.023
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Norway
- South-Eastern Norway Regional Health Authority
This publication has 35 references indexed in Scilit:
- DNA Damage and Repair in Atherosclerosis: Current Insights and Future PerspectivesInternational Journal of Molecular Sciences, 2012
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Release from quiescence stimulates the expression of human NEIL3 under the control of the Ras dependent ERK–MAP kinase pathwayDNA Repair, 2012
- Endonuclease VIII-like 3 (Neil3) DNA glycosylase promotes neurogenesis induced by hypoxia-ischemiaProceedings of the National Academy of Sciences of the United States of America, 2011
- The mouse ortholog of NEIL3 is a functional DNA glycosylase in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2010
- Absence of Akt1 Reduces Vascular Smooth Muscle Cell Migration and Survival and Induces Features of Plaque Vulnerability and Cardiac Dysfunction During AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical TreatmentThe American Journal of Medicine, 2009
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Site Specificity of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Akt Controls Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Delaying G1/S ExitCirculation Research, 2003